Metabolic HealthGLP-1 Drugs Plus Testosterone Therapy May Reverse Male Hormone Decline From Obesity
Obesity often causes functional hypogonadism in men, leading to low testosterone, fatigue, depression, and sexual dysfunction. This comprehensive review reveals that combining GLP-1 receptor agonists (like Ozempic) with testosterone therapy may offer superior results compared to either treatment alone. While GLP-1 drugs provide dramatic weight loss and metabolic benefits, they can reduce muscle mass. Adding testosterone therapy may preserve lean muscle while addressing hormone deficiency. The combination approach targets multiple aging-related issues simultaneously: metabolic dysfunction, cardiovascular risk, sexual health, cognitive function, and bone strength, potentially offering a more complete solution for obese men.
